AIDSinfo

Background

AIDSinfo is a U.S. Department of Health and Human Services (DHHS) project providing information on HIV/AIDS clinical trials and treatment. It is the result of merging two previous DHHS projects: The AIDS Clinical Trials Information Service (ACTIS) and the HIV/AIDS Treatment Information Service (ATIS).

AIDSinfo is a central resource for current information on federally and privately funded clinical trials for AIDS patients and others infected with HIV. AIDS clinical trials evaluate experimental drugs and other therapies for adults and children at all stages of HIV infection -- from patients who are HIV positive with no symptoms to those with various symptoms of AIDS.

As the main dissemination point for federally approved HIV treatment and prevention guidelines, AIDSinfo provides information about the current treatment regimens for HIV infection and AIDS-related illnesses, including the prevention of HIV transmission from occupational exposure and mother-to-child transmission during pregnancy.

Mission Statement

To offer the latest federally approved information on HIV/AIDS clinical research, treatment and prevention, and medical practice guidelines for consumers and health care providers.

Audience

HIV/AIDS patients, their families and friends, health care providers and researchers.

How to Reach AIDSinfo

AIDSinfo
P.O. Box 6303
Rockville, MD 20849-6303

Hotline available from Monday to Friday, 12 p.m. to 5 p.m. (Eastern Time)
Phone: 1.800.HIV.0440 (1.800.448.0440)
Fax: 1.301.315.2818
Outside U.S.: 1.301.315.2816
TTY: 1.888.480.3739

E-mail: ContactUs@AIDSinfo.nih.gov
Web: www.aidsinfo.nih.gov

Chat: Live Help available Monday to Friday, 12 p.m. to 4 p.m. (Eastern Time)
English
Spanish

Latest by AIDSinfo

HHS Adult and Adolescent Antiretroviral Treatment Guidelines Updated

A list of key changes to the updated version of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV.

By AIDSinfo

An Overview of Triumeq (Abacavir/Dolutegravir/Lamivudine)

Brand Name: Triumeq Other Name(s): ABC/DTG/3TC, abacavir sulfate/dolutegravir sodium/lamivudine Drug Class: Combination Drugs

By AIDSinfo

An Overview of Tybost (Cobicistat)

Brand Name: Tybost Other Names: COBI Drug Class: Pharmacokinetic enhancers (CYP3A inhibitors)

By AIDSinfo

An Overview of Prezcobix (Darunavir/Cobicistat)

Brand Name: Prezcobix Other Names: DRV/COBI, darunavir ethanolate/cobicistat Drug Class: Combination Drugs

WARNING:

By AIDSinfo

An Overview of Lamivudine/Tenofovir Disoproxil Fumarate (Cimduo)

Brand Name: Cimduo Other Names: 3TC/TDF, Lamivudine/Tenofovir Disoproxil Fumarate Drug Class: Nucleoside Reverse Transcriptase Inhibitors

WARNING:Cimduo can cause serious, life-threatening side effects. These include a buildup of lactic acid in the ...

By AIDSinfo

An Overview of Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate (Symfi Lo)

Brand Name: Symfi Lo Other Names: EFV/3TC/TDF, Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate Drug Class: Combination Drugs

WARNING:Symfi Lo can cause serious, life-threatening side effects. These include a buildup of lactic acid in the blood (l...

By AIDSinfo

HIV and Immunizations

Key PointsVaccines protect people from diseases such as chicken pox, influenza (flu), and polio. Vaccines are given by needle injection (a shot), by mouth, or sprayed into the nose. The process of getting a vaccine is called vaccination or immunizati...

By AIDSinfo

An Overview of Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy)

Brand Name: Biktarvy Other Names: BIC/FTC/TAF, bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate Drug Class: Combination Drugs

By AIDSinfo

An Overview of Censavudine (Festinavir)

Other Names: 4'-Ed4T, 4'-ethynyl-d4T, 4'-ethynylstavudine, BMS-986001, OBP-601, festinavir Drug Class: Nucleoside Reverse Transcriptase Inhibitors Molecular Formula: C12 H12 N2 O4 Registry Number: 634907-30-5 (CAS) Chemical Name: 1-[(2R,5R)-5-ethyny...

By AIDSinfo

An Overview of Dolutegravir/Rilpivirine (Juluca)

Brand Name: Juluca Other Name(s): DTG/RPV, dolutegravir sodium/rilpivirine hydrochloride Drug Class: Combination Drugs

WARNING:Juluca can cause serious, life-threatening side effects. These include severe skin rash and allergic reactions, liver prob...

By AIDSinfo